Comparing two surgical methods for pancreatic head cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial compares two standard surgical techniques for removing pancreatic head tumors: the usual surgery (partial pancreatoduodenectomy) versus a more extended version that removes additional tissue. The goal is to see which approach offers better outcomes for patients, potentially improving survival or reducing recurrence.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with pancreatic cancer in the head of the pancreas (the part nearest the small intestine), including certain types like adenocarcinoma or IPMN-related cancer.
- Your tumor is considered removable by surgery (resectable or borderline resectable), or if it's locally advanced, your doctor still plans to operate.
- You are willing and able to give written consent to participate.
- You are not participating in another clinical trial that would interfere with this one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two approaches for patients with pancreatic or periampullary cancer that can be surgically removed: getting chemotherapy before surgery (neoadjuvant therapy) versus surgery first. It aims to find out which sequence leads to better outcomes.
This trial compares two types of surgery to remove tumors that start near the pancreas but not in it. The goal is to see if a newer, less invasive method works as well as the standard approach, which may mean fewer cuts and a faster recovery.
This trial compares two ways to reconnect the intestines after surgery to remove the head of the pancreas. The goal is to see which method leads to fewer complications and better recovery.
This trial compares two types of surgery for removing pancreatic cancer in the body or tail of the pancreas. One is a more involved surgery that removes more tissue around the pancreas, and the other is a more standard removal. The goal is to see if the more extensive surgery improves outcomes or not.
This trial compares two ways of doing the same surgery to remove a tumor in the pancreas. It looks at whether removing the blood supply to the tumor first makes the surgery safer or more effective than the usual method.
This trial compares a modified surgical technique to the standard one for removing pancreatic tumors. It aims to see if the new method lowers the risk of a leak from the pancreas after surgery.
Hear when a new Pancreatic Cancer Resectable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.